---
$id: https://graph.org.ai/products/commodity/51241131
$type: Product
source: UNSPSC
code: "51241131"
title: "Brimonidine tartrate"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Brimonidine tartrate

**UNSPSC Code**: 51241131
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H10BrN5.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4S9CL2DY2H, chemically known as 6-quinoxalinamine, 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)- (9ci) but generally known as brimonidine tartrate, which bears US NIH Compound Identifier 2435. European Medicines Agency schedules Brimonidine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13122MIG. Most nations schedule brimonidine tartrate under HS 29332990 and SITC 51573. As of Q4 2014, BRIMONIDINE TARTRATE remains the US FDA Preferred Term for this commodity. Brimonidine tartrate bears US NLM identifiers UMLS ID C0077768 and NCI Concept Code C47419. SMILES: C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O.

